Approximation error

CenTrak Announces Partnership with The Leapfrog Group

Retrieved on: 
måndag, juni 3, 2024

NEWTOWN, Pa., June 03, 2024 (GLOBE NEWSWIRE) -- CenTrak , the leader in real-time location technology solutions, announces its partnership with The Leapfrog Group, an independent national watchdog organization focused on healthcare safety.

Key Points: 
  • NEWTOWN, Pa., June 03, 2024 (GLOBE NEWSWIRE) -- CenTrak , the leader in real-time location technology solutions, announces its partnership with The Leapfrog Group, an independent national watchdog organization focused on healthcare safety.
  • Hand HygieneRT provides automated compliance reporting that can help meet the stringent requirements of The Joint Commission and The Leapfrog Group, empowering healthcare organizations with actionable insights to enhance overall performance.
  • With two Leapfrog Certified Coaches among its team members, CenTrak reaffirms its dedication to helping healthcare facilities uphold The Leapfrog Group's high standard for excellence in hand hygiene and enhancing overall patient safety.
  • Every American deserves the highest quality care, and together with CenTrak we can achieve our shared vision for excellence,” said Leah Binder, Leapfrog president & CEO.

Vyluma Announces Marketing Authorization Application Validation for the European Union

Retrieved on: 
onsdag, maj 29, 2024

BRIDGEWATER, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a biopharmaceutical company dedicated to advancing novel ophthalmic solutions for refractive errors, announced today that the European Medicines Agency (EMA) has validated the Marketing Authorisation Application (MAA) for its lead compound, NVK002.

Key Points: 
  • BRIDGEWATER, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a biopharmaceutical company dedicated to advancing novel ophthalmic solutions for refractive errors, announced today that the European Medicines Agency (EMA) has validated the Marketing Authorisation Application (MAA) for its lead compound, NVK002.
  • The application is confirmed to be eligible for a Paediatric Use Marketing Authorisation (PUMA), providing 10 years of data exclusivity and marketing protection upon product approval.
  • “This acceptance represents an important and key milestone for our Company, as NVK002 has now been submitted for regulatory review across our three most key global markets: the U.S., China, and the European Union,” stated Raul A. Trillo, MD, MBA, President, and Chief Commercial Officer of Vyluma.
  • “Our steadfast commitment to delivering an innovative pharmaceutical option for pediatric myopia underscores our dedication to improving children’s vision worldwide.”
    The regulatory application of NVK002 is supported by previously reported safety and efficacy data from the multi-center, placebo-controlled, Phase III CHAMP (Childhood Atropine Myopia Progression) clinical study which evaluated the safety and efficacy of the product in children aged three years and older.

IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants

Retrieved on: 
tisdag, maj 28, 2024

IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants

Key Points: 

    Global Healthcare CRM Market Analysis 2024-2032: Rising Need for Cost-Effective Healthcare Solutions, Focus on Lowering Manual Administrative Tasks - ResearchAndMarkets.com

    Retrieved on: 
    fredag, maj 24, 2024

    Market Growth and Size: The market is witnessing strong growth on account of the increasing need for cost-effective healthcare solutions, along with the rising focus on lowering manual administrative tasks.

    Key Points: 
    • Market Growth and Size: The market is witnessing strong growth on account of the increasing need for cost-effective healthcare solutions, along with the rising focus on lowering manual administrative tasks.
    • Future Outlook: The future of the healthcare CRM market looks promising, with the rising need for personalized treatment solutions among individuals.
    • What is the breakup of the global healthcare CRM market based on the product?
    • What is the breakup of the global healthcare CRM market based on the end use?

    Prime Healthcare Hospitals Recognized Among Nation's Best by The Leapfrog Group

    Retrieved on: 
    måndag, maj 20, 2024

    Prime Healthcare today announces that 27 of its hospitals across 12 states were awarded an "A" Leapfrog Hospital Safety Grade for Spring 2024.

    Key Points: 
    • Prime Healthcare today announces that 27 of its hospitals across 12 states were awarded an "A" Leapfrog Hospital Safety Grade for Spring 2024.
    • This national distinction recognizes Prime Healthcare's hospitals among the top in the nation in protecting patients from preventable harm and errors.
    • (Photo: Business Wire)
      In the last year, 81 percent of Prime's hospitals earned "A" grades from The Leapfrog Group.
    • "Everyone who works at Prime Healthcare's hospitals should be proud of this 'A' Hospital Safety Grade," said Leah Binder, president and CEO of The Leapfrog Group.

    ECP Uses AI to Improve Medication Safety in Over 7,500 Senior Living Communities

    Retrieved on: 
    onsdag, maj 15, 2024

    ECP , leading provider of software to over 7,500 senior living and other long-term care communities, announced the release of a suite of AI-powered tools to significantly improve medication safety and improve clinical outcomes for senior living residents.

    Key Points: 
    • ECP , leading provider of software to over 7,500 senior living and other long-term care communities, announced the release of a suite of AI-powered tools to significantly improve medication safety and improve clinical outcomes for senior living residents.
    • ECP's AI-powered medication safety features include:
      Duplicate Medication Prevention: ECP’s software compares medication orders in real-time during the medication approval process, alerting staff of potential duplicate medications (e.g.
    • "ECP is excited to be leading the industry in intelligent methods of improving medication adherence and safety in senior living communities.
    • While AI can help communities improve medication safety, the ultimate responsibility for safely passing medications ultimately falls on the community and the med passer.

    Watershed Health Secures $13.6M in Funding to Fuel Adoption by the Industry’s Largest Health Plans and Meet Provider Demand for Real-Time, Seamless Patient Care Coordination

    Retrieved on: 
    torsdag, maj 16, 2024

    “My work as a physician has shown me the consequences of uncoordinated care – the missed connections and the inefficiencies.

    Key Points: 
    • “My work as a physician has shown me the consequences of uncoordinated care – the missed connections and the inefficiencies.
    • ”Watershed offers a comprehensive view of a patient's health, empowering providers to make informed decisions at the point of care.
    • “He and his team understand the challenges of providing patient care in a system where communication and collaboration are often lacking.
    • Watershed is intentionally designed to cut through the noise and solve the massive problem of fragmented care.”

    Zebra Study: 84% of U.S. and UK Hospital Leaders Prioritize Digitizing Inventory Management Solutions

    Retrieved on: 
    måndag, maj 13, 2024

    Most (84%) hospital leaders acknowledge their role and responsibility in tracking and managing hospital inventory directly impacts patient safety.

    Key Points: 
    • Most (84%) hospital leaders acknowledge their role and responsibility in tracking and managing hospital inventory directly impacts patient safety.
    • The Zebra study also confirmed that outdated or disparate inventory systems get in the way of accurately managing inventory.
    • Nearly eight in 10 (78%) hospital leaders also say it’s a priority to use data and analytics to improve materials management.
    • Zebra’s study revealed a link between hospital leaders’ materials management and clinicians’ efficiency, productivity, and ability to provide the best patient care.

    EQUASHIELD® Marks 15 Years of Innovation in Healthcare Safety, Remaining the Top Choice CSTD for Hazardous Drug Preparation for Six Consecutive Years

    Retrieved on: 
    måndag, maj 13, 2024

    PORT WASHINGTON, N.Y., May 13, 2024 /PRNewswire/ -- EQUASHIELD®, a global leader in the development and distribution of Closed System Transfer Devices (CSTDs) and pharmacy automation solutions, marks its 15th year of innovation and excellence. This anniversary is highlighted by the brand's recognition as the "Most Used CSTD for Drug Preparation" by Pharmacy Purchasing and Products1 for an impressive sixth consecutive year. Demonstrating its commitment to healthcare safety and innovation, EQUASHIELD® is also the first choice among facilities considering CSTDs.

    Key Points: 
    • This anniversary is highlighted by the brand's recognition as the "Most Used CSTD for Drug Preparation" by Pharmacy Purchasing and Products 1 for an impressive sixth consecutive year.
    • Demonstrating its commitment to healthcare safety and innovation, EQUASHIELD® is also the first choice among facilities considering CSTDs.
    • Since its inception, EQUASHIELD® has been a forerunner in driving advancements in safety and efficiency for healthcare workers handling hazardous drugs.
    • The Mundus Mini HD represents our forward-thinking approach to healthcare safety, heralding a new era of innovation."

    CORRECTION: New York Sen. Michelle Hinchey, Emma Heming Willis Join Families of People With Frontotemporal Degeneration To Call For Increased Awareness And Research Into Underdiagnosed Disease

    Retrieved on: 
    måndag, maj 6, 2024

    Sen. Hinchey, whose father died of FTD in 2017, sponsored the first-ever resolution recognizing FTD Awareness Week in New York.

    Key Points: 
    • Sen. Hinchey, whose father died of FTD in 2017, sponsored the first-ever resolution recognizing FTD Awareness Week in New York.
    • She said her father’s diagnosis sparked her interest in using her platform to advocate for FTD legislation.
    • In a conversation with Susan Dickinson, CEO of The Association for Frontotemporal Degeneration, Willis spoke warmly about the support she has received from the FTD community.
    • “We are grateful to Emma and Sen. Hinchey for championing awareness of FTD, a disease that was hardly known just a couple years ago.